Maintaining storage temperatures between 36F and 46F (2C to 8C) is essential for preserving the medications stability and potency
Now, two new late-phase clinical trials, sponsored by Eli Lilly and Company, suggest that transitioning from high dose injectable weight loss medications to either a daily pill or a lower maintenance dose can help people living with obesity to keep off most of the weight they have already lost The results of the ATTAIN-MAINTAIN and SURMOUNT-MAINTAIN trials were presented at the European Congress on Obesity and published in Previous research suggests that 1 year after stopping weight loss medication, people may regain, on average, 60% of their lost weight
They give you usable energy when appetite is low, and they can be easier to tolerate than richer foods during waves of nausea
Asian Pacific journal of tropical biomedicine, 3 (4), 253266.
PlexusDx's Precision Peptide Genetic Test identifies these predispositions by examining GLP1R rs6923761 and related variants across 14 metabolic pathways
